Alireza R Rezaie Selected Research

Alireza R Rezaie Research Topics

Disease

11	Inflammation (Inflammations) 01/2022 - 06/2009
9	Autolysis 05/2008 - 05/2002
8	Hemorrhage 07/2022 - 03/2007
6	Thrombosis (Thrombus) 07/2022 - 01/2017
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2017
5	Sepsis (Septicemia) 11/2015 - 08/2007
2	Venous Thromboembolism 07/2022 - 07/2017
2	Infections 01/2020 - 11/2015
2	Neoplasms (Cancer) 04/2019 - 03/2007
2	Polyps 01/2018 - 02/2014
2	Melanoma (Melanoma, Malignant) 01/2018 - 02/2014
2	Endotoxemia 10/2017 - 11/2015
2	Reperfusion Injury 01/2016 - 02/2015
2	Necrosis 03/2009 - 03/2007
1	Hypersensitivity (Allergy) 12/2023
1	Peritoneal Fibrosis 01/2023
1	Thrombocytopenia (Thrombopenia) 07/2022
1	Hemophilia A (Haemophilia) 07/2022
1	Thromboinflammation 07/2022
1	Dysprothrombinemia 01/2022
1	COVID-19 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Malaria 01/2020
1	Cardiovascular Infections 04/2019
1	Heart Failure 04/2019
1	Heart Diseases (Heart Disease) 04/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Hypertrophy 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Peritonitis 10/2017
1	Thrombophilia 07/2017
1	Pulmonary Embolism 01/2017
1	Activated Protein C Resistance (APC Resistance) 11/2015
1	Hemophilia B (Haemophilia B) 06/2015
1	Vascular Diseases (Vascular Disease) 11/2013
1	Acute Kidney Injury (Acute Renal Failure) 10/2010

Drug/Important Bio-Agent (IBA)

20	Protein CIBA 01/2023 - 09/2004
14	AnticoagulantsIBA 01/2023 - 09/2004
10	AntithrombinsIBA 01/2022 - 05/2002
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2004
8	Thrombin FDA Link 09/2014 - 09/2004
8	Peptide Hydrolases (Proteases)FDA Link 02/2014 - 05/2002
7	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 07/2003
6	SerpinsIBA 07/2017 - 07/2003
5	Protein SIBA 07/2017 - 07/2005
4	Endothelial Protein C ReceptorIBA 01/2023 - 03/2007
4	HMGB1 Protein (HMG1)IBA 01/2018 - 10/2011
3	CytokinesIBA 01/2023 - 03/2009
3	AntigensIBA 01/2022 - 01/2017
3	PolyphosphatesIBA 01/2020 - 02/2014
3	Peptides (Polypeptides)IBA 01/2018 - 03/2009
3	Factor X (Stuart Factor)IBA 11/2014 - 07/2005
3	ChymotrypsinogenIBA 11/2014 - 07/2003
3	Factor Xa (Coagulation Factor Xa)IBA 09/2005 - 05/2002
2	Histidine (L-Histidine)FDA Link 01/2022 - 01/2020
2	Prothrombin (Factor II)IBA 01/2022 - 07/2017
2	Histones (Histone)IBA 10/2021 - 02/2014
2	Epidermal Growth Factor (EGF)IBA 01/2020 - 09/2005
2	AMP-Activated Protein KinasesIBA 04/2019 - 02/2015
2	IntegrinsIBA 10/2017 - 04/2009
2	Chymotrypsin FDA Link 05/2008 - 09/2004
2	Serine Proteases (Serine Protease)IBA 08/2006 - 09/2004
1	Angiopoietin-1IBA 12/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2023
1	VimentinIBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2023
1	Ethanol (Ethyl Alcohol)IBA 01/2023
1	CollagenIBA 01/2023
1	VaccinesIBA 07/2022
1	Poly I-CIBA 11/2021
1	GlycosaminoglycansIBA 10/2021
1	Viral ProteinsIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 04/2019
1	Mitogen-Activated Protein KinasesIBA 04/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2019
1	von Willebrand FactorIBA 01/2018
1	Integrin alpha3beta1IBA 10/2017
1	factor V LeidenIBA 07/2017
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2017
1	prothrombin complex concentrates (PPSB)IBA 01/2017
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 06/2015
1	Codon (Codons)IBA 11/2014
1	Adenosine (Adenocard)FDA LinkGeneric 09/2014
1	Purinergic P2Y1 ReceptorsIBA 02/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 02/2014
1	Small Interfering RNA (siRNA)IBA 02/2014
1	Receptor for Advanced Glycation End ProductsIBA 02/2014
1	Pattern Recognition ReceptorsIBA 02/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2014
1	ThrombomodulinIBA 02/2014
1	Messenger RNA (mRNA)IBA 02/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2010
1	Phospholipases (Phospholipase)IBA 01/2010
1	Proteinase-Activated ReceptorsIBA 06/2009
1	drotrecogin alfa activated (Xigris)FDA Link 04/2009

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2015